SCHEMBL9512937

SCHEMBL9512937

Cc1cccc(C)c1NC(=O)c1ccon1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
HTT P42858 1/20 0.48
POLB P06746 2/20 0.47
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ACR P10323 1/20 0.46
S1PR4 O95977 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 1/20 0.41
S1PR2 O95136 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14825173 0.78 POLB (0.56) TSHRHTTPOLBALDH1A1L3MBTL1
SCHEMBL9510816 0.77 MAPT (0.63) HTTALDH1A1ACRSMN1; SMN2MAPT
SCHEMBL21348471 0.77 SMN1; SMN2 (0.64) ALDH1A1L3MBTL1ACRSMN1; SMN2MAPT
SCHEMBL6633619 0.75 POLB (0.58) HTTPOLBALDH1A1SMN1; SMN2NFKB1
SCHEMBL32060705 0.73 NPC1 (0.69) POLBL3MBTL1SMN1; SMN2MAPTNPC1
SCHEMBL28153253 0.73 GRM5 (0.68) TSHRHTTPOLBALDH1A1L3MBTL1
SCHEMBL10038817 0.73 NPC1 (0.69) POLBL3MBTL1SMN1; SMN2MAPTNPC1
SCHEMBL755315 0.73
SCHEMBL31501093 0.73 NPC1 (0.49) POLBALDH1A1L3MBTL1ACRS1PR4
SCHEMBL9512456 0.73 GAA (0.71) HTTALDH1A1L3MBTL1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371876-B1 Isoxazoles and isoxazolines with an anticonvulsive activity, and pharmaceutical compositions containing them NOVAPHARME (FR) 1993-11-24 EP claimed
US-5059614-A NOVEL ISOXAZOLE AND ISOXAZOLINE COMPOUNDS WITH ANTICONVULSANT ACTIVITY PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THEM NOVAPHARME (FR) 1991-10-22 US claimed
US-5059614-A NOVEL ISOXAZOLE AND ISOXAZOLINE COMPOUNDS WITH ANTICONVULSANT ACTIVITY PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THEM NOVAPHARME (FR) 1991-10-22 US disclosed